Novartis Sues Sun Pharma Over Exelon ANDA
Swiss pharmaceutical giant Novartis Pharmaceuticals has sued India's Sun Pharmaceuticals in Delaware federal court over its to make generic versions of Alzheimer treatment Exelon....To view the full article, register now.
Already a subscriber? Click here to view full article